MedPath

Pain relief from epidural in laparoscopic surgery

Phase 1
Conditions
Health Condition 1: K928- Other specified diseases of the digestive systemHealth Condition 2: K928- Other specified diseases of the digestive system
Registration Number
CTRI/2018/12/016559
Lead Sponsor
Amrita Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of ASA physical status I, II and III presenting for elective laparoscopic abdominal surgery

Exclusion Criteria

Contraindication for epidural anaesthesia, BMI > 35,severe CAD EF < 35%, COPD Class III and above, CKD class III

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analgesic effect of epidural ropivacaine in laparoscopic abdominal surgeryTimepoint: MAP more than 20 percent from baseline during surgery
Secondary Outcome Measures
NameTimeMethod
1. Postoperative analgesia measured ny NRS and OPS <br/ ><br>2. LOICU stay <br/ ><br>3. Time to ambulation <br/ ><br>4. Duration of catheterisationTimepoint: 6th hrly for 24 h postoperatively
© Copyright 2025. All Rights Reserved by MedPath